Author: Kipkorir, Terry; Tittman, Sarah; Botsios, Sotirios; Manuelidis, Laura
Title: Highly Infectious CJD Particles Lack Prion Protein but Contain Many Viralâ€Linked Peptides by LCâ€MS/MS Cord-id: oiism2ui Document date: 2014_9_10
ID: oiism2ui
Snippet: It is widely believed that host prion protein (PrP), without nucleic acid, converts itself into an infectious form (PrPâ€res) that causes transmissible encephalopathies (TSEs), such as human sporadic CJD (sCJD), endemic sheep scrapie, and epidemic BSE. There are many detailed investigations of PrP, but proteomic studies of other proteins in verified infectious TSE particles have not been pursued, even though brain homogenates without PrP retain their complete infectious titer. To define protein
Document: It is widely believed that host prion protein (PrP), without nucleic acid, converts itself into an infectious form (PrPâ€res) that causes transmissible encephalopathies (TSEs), such as human sporadic CJD (sCJD), endemic sheep scrapie, and epidemic BSE. There are many detailed investigations of PrP, but proteomic studies of other proteins in verified infectious TSE particles have not been pursued, even though brain homogenates without PrP retain their complete infectious titer. To define proteins that may be integral to, process, or protect an agent genome, we developed a streamlined, highâ€yield purification of infectious FUâ€CJD mouse brain particles with minimal PrP. Proteinase K (PK) abolished all residual particle PrP, but did not reduce infectivity, and viralâ€size particles lacking PrP were ∼70S (vs. 90–120S without PK). Furthermore, over 1,500 nonâ€PrP proteins were still present and positively identified in high titer FUâ€CJD particles without detectable PrP by mass spectrometry (LCâ€MS/MS); 114 of these peptides were linked to viral motifs in the environmental–viral database, and not evident in parallel uninfected controls. Host components were also identified in both PK and nonâ€PK treated particles from FUâ€CJD mouse brain and human sCJD brain. This abundant cellular data had several surprises, including finding Huntingtin in the sCJD but not normal human brain samples. Similarly, the neural Wiskott–Aldrich sequence and multivesicular and endosome components associated with retromer APP (Alzheimer amyloid) processing were only in sCJD. These cellular findings suggest that new therapies directed at retromer–vesicular trafficking in other neurodegenerative diseases may also counteract lateâ€onset sCJD PrP amyloid pathology. J. Cell. Biochem. 115: 2012–2021, 2014. © 2014 Wiley Periodicals, Inc.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date